322 resultados para altered peptide ligands

Glucagon-like peptide-1 protects against cardiac remodeling after myocardial infarction via specific actions on the extracellular matrix.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Glucagon-like peptide-1 protects against cardiac dysfunction and extracellular matrix remodelling in experimental diabetes.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Glucagon-like peptide-1 improves cardiac function and protects against cardiac remodeling after myocardial infarction via specific actions on the extracellular matrix

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Glucagon-like peptide-1 protects against adverse post-myocardial infarction remodeling via specific actions on inflammation and the extracellular matrix

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Ultrashort Self-assembling Peptide Nanomaterials for Biomedical Applications

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Contribution of altered expression of α1a-adrenoceptors and P2X1 purinergic receptors to functional changes in tail arteries of streptozotocin-induced diabetic rats and Akita mice (Proc Physiol Soc 15 PC10)

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Altered cotransmitter contributions to sympathetic vasoconstriction in tail artery of streptozotocin diabetic rats (J. Physiol. 539P, 104P)

Relevância:

20.00% 20.00%

Publicador:

Veja mais

N-acetyl glucagon-like peptide-1 is resistant to dipeptidyl-peptidase IV and exhibits strong insulinotropic activity.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Novel stable Val8 glucagon-like peptide-1 analogue with potent insulin releasing activity.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Enhanced plasma stability, receptor binding, cyclic AMP production and insulin-releasing activity of two novel penultimate N-terminally substituted analogues of glucagon-like peptide-1.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Development and characterisation of novel N-terminal Glu9-substituted agonists of glucagon-like peptide-1 (GLP-1).

Relevância:

20.00% 20.00%

Publicador:

Veja mais

The truncated incretin hormone glucagon-like peptide-1(9-36)amide has a significant effect on glucose disposal in vitro and in vivo.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

The truncated peptide glucagon-like peptide-1(9-36)amide has no insulin releasing activity but retains a significant effect on glucose disposal in vitro and in vivo.

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Irish seaweed species inhibit alpha-glucosidase, stimulate secretion of glucagon-like peptide-1 (GLP-1) and inhibit dipeptidyl peptidase 4 (DPP4): potential for therapy of type 2 diabetes mellitus?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

In vitro Evaluation of a Novel Injectable Thermo-Responsive Polymeric Hydrogel for the Delivery of Self-Assembly Peptide Nanoparticles Containing an Osteoconductive Agent

Relevância:

20.00% 20.00%

Publicador:

Veja mais